Expression of CD304/neuropilin‐1 in adult b‐cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Expression of CD304/neuropilin‐1 in adult b‐cell lymphoblastic leukemia/lymphoma and its utility for the measurable residual disease assessment

Published:2021-01-12 Issue:5 Volume:43 Page:990-999
ISSN:1751-5521
Container-title:International Journal of Laboratory Hematology
language:en
Short-container-title:Int J Lab Hematol

Author:

Chatterjee Gaurav¹^ORCID,Dudakia Vishesh¹,Ghogale Sitaram¹,Deshpande Nilesh¹,Girase Karishma¹,Chaturvedi Anumeha¹,Shetty Dhanlaxmi²,Senger Manju³,Jain Hasmukh³,Bagal Bhausaheb³,Bonda Avinash³,Punatar Sachin³,Gokarn Anant³,Khattry Navin³,Patkar Nikhil V.¹,Gujral Sumeet⁴,Subramanian Papagudi G.¹,Tembhare Prashant R.¹^ORCID

Affiliation:

1. Department of Hematopathology Laboratory ACTREC Tata Memorial Center HBNI University Navi Mumbai India

2. Department of Department of Cancer Cytogenetics ACTREC Tata Memorial Center HBNI University Navi Mumbai India

3. Department of Medical Oncology Tata Memorial Center, HBNI University Mumbai India

4. Department of Pathology Tata Memorial Center, HBNI University Mumbai India

Publisher

Wiley

Subject

Biochemistry, medical,Clinical Biochemistry,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijlh.13456

Reference38 articles.

1. Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible

2. Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia

3. Clinical utility of sequential minimal residual disease measurements in the context of risk-based therapy in childhood acute lymphoblastic leukaemia: a prospective study

4. Minimal residual disease diagnostics in acute lymphoblastic leukaemia: impact of primer characteristics and size of junctional regions

5. Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolving Landscape of Flowcytometric Minimal Residual Disease Monitoring in B-Cell Precursor Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-04-30

2. 15‐color highly sensitive flow cytometry assay for post anti‐CD19 targeted therapy (anti‐CD19‐CAR‐T and blinatumomab) measurable residual disease assessment in B‐lymphoblastic leukemia/lymphoma: Real‐world applicability and challenges;European Journal of Haematology;2023-09-14

3. Minimal Residual Disease in the Management of B-Cell Acute Lymphoblastic Leukemia: A Systematic Review of Studies from Indian Settings;Indian Journal of Hematology and Blood Transfusion;2023-03-30

4. Evaluation of diagnostic efficacy of NRP‐1/CD304 in hematological diseases;Cancer Medicine;2023-03-25

5. Evaluation of Diagnostic Efficacy of NRP-1/CD304 in Hematological Diseases;2022-11-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3